CAMBRIDGE NUTRITIONAL SCIENCES PLC (CNSL) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the Cambridge Research and Sciences PLC interim results investor presentation. Throughout this quarter presentation, investors will be in listen only mode. Questions are encouraged, and they can be submitted at any time using the q and a tab situated in the right corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question it receives in the meeting itself. However, the company can review all the questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to James Cooper, CEO. Good afternoon to you, sir. Good afternoon, everyone, and welcome to the Cambridge Intrational Sciences interim results presentation for the six months ended September 2024. I'd like to start this presentation by introducing our new nonexecutive chair of the board, Carolyn Rand, who was appointed chair on the twenty second of April this year. I'll just pass over to her for a brief introduction. Good afternoon. It's really nice to speak to you all. I'm a professional non exec director. I sit on a number of PLC boards in technology and science. And joining the board was a real positive choice for me. CAMBRIDGE NUTRITIONAL SCIENCES has some strong diagnostic products in the personalized health and well-being space, which is a growing global market as more people become aware of the importance of gut health and general well-being. Our initial focus has been on improving operations and margins. And our focus is now shifting towards developing our sales and marketing and the capabilities of our future development. And I'm gonna as you can see, we're joined by James, our interim CEO, who'll t...